b2venture

Calvin Risk is a Zurich-based company that specializes in developing comprehensive solutions for assessing and managing the risks associated with commercial AI algorithms. Its risk assessment framework and management platform facilitate the evaluation and mitigation of potential risks, enabling industries such as insurance, banking, retail, and telecommunications to effectively manage their exposure to AI-related incidents. The platform consolidates models and specifications in one location, allowing for a thorough analysis of negative consequences and promoting reliable and responsible AI usage.

Calvin Risk is a Zurich-based company that specializes in developing comprehensive solutions for assessing and managing the risks associated with commercial AI algorithms. Its risk assessment framework and management platform facilitate the evaluation and mitigation of potential risks, enabling industries such as insurance, banking, retail, and telecommunications to effectively manage their exposure to AI-related incidents. The platform consolidates models and specifications in one location, allowing for a thorough analysis of negative consequences and promoting reliable and responsible AI usage.

Calvin Risk is a Zurich-based company that specializes in developing comprehensive solutions for assessing and managing the risks associated with commercial AI algorithms. Its risk assessment framework and management platform facilitate the evaluation and mitigation of potential risks, enabling industries such as insurance, banking, retail, and telecommunications to effectively manage their exposure to AI-related incidents. The platform consolidates models and specifications in one location, allowing for a thorough analysis of negative consequences and promoting reliable and responsible AI usage.

Araris Biotech AG is a biotechnology start-up based in Zurich, Switzerland, founded in 2019. The company specializes in developing antibody-drug conjugate (ADC) linker technology aimed at enhancing chemotherapy by delivering drugs directly to targeted antibodies. This innovative approach allows for the creation of next-generation ADCs that are both safe and effective for treating various diseases, including cancer. Araris' platform enables the production of high-quality ADCs without the need for extensive engineering of antibodies or cell lines, allowing for rapid development and manufacturing processes. The technology is supported by two patents and focuses on site-specific conjugation, enabling the use of readily available antibodies. This streamlined production method facilitates quick quality control and analysis, enhancing the overall efficiency and reliability of ADC development.

Skribble is a Zurich-based platform that specializes in electronic signatures, enabling users to sign contracts digitally while ensuring that these signatures carry the same legal weight as handwritten ones under Swiss and EU law. Founded in 2018, Skribble provides a user-friendly interface that allows individuals and businesses to sign documents with a few clicks, streamlining the process of contract management. The platform incorporates signature management systems that facilitate the identification of signers, ensuring compliance with legal requirements. Through its services, Skribble aims to simplify the process of creating legally binding agreements in a digital format.

Araris Biotech AG is a biotechnology start-up based in Zurich, Switzerland, founded in 2019. The company specializes in developing antibody-drug conjugate (ADC) linker technology aimed at enhancing chemotherapy by delivering drugs directly to targeted antibodies. This innovative approach allows for the creation of next-generation ADCs that are both safe and effective for treating various diseases, including cancer. Araris' platform enables the production of high-quality ADCs without the need for extensive engineering of antibodies or cell lines, allowing for rapid development and manufacturing processes. The technology is supported by two patents and focuses on site-specific conjugation, enabling the use of readily available antibodies. This streamlined production method facilitates quick quality control and analysis, enhancing the overall efficiency and reliability of ADC development.

Skribble is a Zurich-based platform that specializes in electronic signatures, enabling users to sign contracts digitally while ensuring that these signatures carry the same legal weight as handwritten ones under Swiss and EU law. Founded in 2018, Skribble provides a user-friendly interface that allows individuals and businesses to sign documents with a few clicks, streamlining the process of contract management. The platform incorporates signature management systems that facilitate the identification of signers, ensuring compliance with legal requirements. Through its services, Skribble aims to simplify the process of creating legally binding agreements in a digital format.

DeepCode AG, established in 2016 and headquartered in Zurich, Switzerland, specializes in developing artificial intelligence software for machine learning and programming languages. Its core product is a semantic code analysis tool that automates the understanding of code intent, identifies critical bugs and vulnerabilities, and detects serious coding issues. This enables developers to enhance software quality without manual user annotation or specification. As of 2020, DeepCode operates as a subsidiary of Snyk Ltd.

Skribble is a Zurich-based platform that specializes in electronic signatures, enabling users to sign contracts digitally while ensuring that these signatures carry the same legal weight as handwritten ones under Swiss and EU law. Founded in 2018, Skribble provides a user-friendly interface that allows individuals and businesses to sign documents with a few clicks, streamlining the process of contract management. The platform incorporates signature management systems that facilitate the identification of signers, ensuring compliance with legal requirements. Through its services, Skribble aims to simplify the process of creating legally binding agreements in a digital format.

DeepCode AG, established in 2016 and headquartered in Zurich, Switzerland, specializes in developing artificial intelligence software for machine learning and programming languages. Its core product is a semantic code analysis tool that automates the understanding of code intent, identifies critical bugs and vulnerabilities, and detects serious coding issues. This enables developers to enhance software quality without manual user annotation or specification. As of 2020, DeepCode operates as a subsidiary of Snyk Ltd.

Advanon AG is an online financial services platform based in Zurich, Switzerland, focused on connecting small and medium-sized enterprises (SMEs) with investors. Established in 2015, the platform specializes in invoice financing, allowing SMEs to pre-finance their outstanding invoices. This service enables businesses to access liquidity more quickly, avoiding the lengthy wait times of 30 to 120 days for customer payments. Advanon operates as an authorized financial intermediary under Swiss regulations, ensuring compliance with the Anti Money Laundering Act. By facilitating flexible financing options with transparent pricing, Advanon aims to support the growth and cash flow stability of SMEs.

CodeCheck AG is a Swiss company based in Zurich that has developed a smartphone application designed to help consumers make informed purchasing decisions. Founded in 2007, the CodeCheck app allows users to scan the barcodes of food and cosmetic products in Germany and the USA, providing detailed product descriptions, ingredient lists, and consumer reviews. It offers personalized ratings based on individual user profiles and the latest scientific research, catering to the growing demand for transparency regarding product ingredients and ethical standards. With a user base exceeding 3 million, CodeCheck taps into significant trends in conscious consumption and transparency. Additionally, the company has introduced Oeeda, a market research solution aimed at assisting manufacturers in understanding consumer preferences to drive innovation.